Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer

NCT02522715 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Castration-Resistant Prostate Carcinoma
Metastatic Prostate Carcinoma
Recurrent Prostate Carcinoma
Stage IV Prostate Cancer AJCC v7

Interventions

DRUG: Cabazitaxel
DRUG: Enzalutamide
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
DRUG: Prednisone

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]